Midlands Innovation Flow Cytometry Conference 2026 resources

 

Agenda
*Abstracts for the academic presentations can be found below

09:00 – 09:30 | Registration and Coffee
09:30 – 09:45 | Welcome

Professor Dominique Moran, Deputy Pro-Vice-Chancellor, Research Impact, University of Birmingham.
Professor Lucy Fairclough, Chair of the Midlands Innovation Flow Cytometry Group.
Ferdus Sheik, University of Birmingham Flow Cytometry Platform.

09:45 – 10:45 | Session 1
  • Kristina Tomkova (University of Birmingham) – Integrating Spectral Flow Cytometry and SCENITH to Characterise Age-Associated Metabolic Shifts in Immune Cell Subsets. ABSTRACT 1 
  • Annabelle Bennett (University of Warwick) – Using Spectral Flow Cytometry to Profile 𝛾𝛿 T-cells in Colorectal Cancer Tumours. ABSTRACT 2
  • Bradley Mason (Loughborough University) – Methods to Reduce Variability in Flow Cytometry Cluster Analysis using Computationally Generated High-dimensional Fully-Synthetic data. ABSTRACT 3
  • Giulia Falgari (Miltenyi Biotec) – No Pressure, Just Precision: Lux-urious Next-Gen Sorting with the MACSQuant® Tyto® Lux Cell Sorter.
  • Thomas Adejumo (Bruker Cellular Analysis) – Beacon: Discovery™: Functional Profiling of Diverse Immune Cell types on an Integrated Platform.
10:45 – 11:15 | Coffee Break & Cell Sorter Demonstrations
11:15 – 12:30 | Session 2
  • Emma Davey (University of Warwick) – Illuminating T Cell Signalling: Optogenetics and FRET Sensors in Flow Cytometry. ABSTRACT 4
  • Megan Atherton-Frisby (University of Leicester) – Flow Cytometric quantification of membrane polarisation in mycobacteria. ABSTRACT 5
  • Sofina Iqra (Aston University) – Development of a Flow Cytometry Strategy for Phenotypic Characterisation of Human Placental Pericytes. ABSTRACT 6
  • Bev Goward (SONY) – From MA900 to FP7000: Robust solutions, whatever the flow.
  • Hayden Pearce (Waters Biosciences) – Real-time spatial imaging and Superior Spectral Analysis with the BD FACSDiscover™ flow cytometry platform.
  • Rob Durkin (Beckman Coulter) – CytoFLEX Mosiac – Conventional and Spectral flow cytometry – The best of both worlds.
12:30 – 13:30 | Lunch, Posters, Exhibition & Cell Sorter Demonstrations
13:30 – 14:45 | Session 3
  • Adam Wright (University of Leicester) – Single cell cytokine analysis of blood T cells reveals increased CD8+ multifunctional type-2 cytokine responses during an eosinophilic exacerbation in COPD. ABSTRACT 7
  • Emma Jennings (University of Warwick) – Optimising CAR T-Cell Therapy: Optogenetic Pulsatile Activation Drives Th9 Differentiation in CAR T Cells. ABSTRACT 8
  • Jessica Ting (Aston University) – Fibrosis-associated inflammatory mediators promote pericyte-to-myofibroblast transition. ABSTRACT 9
  • Christina Kovoor (ThermoFisher) – From Complexity to Simplicity: breaking barriers to flow cytometry.
  • Asha Lad (Asha Lad) – Cytek’s Full Spectrum: Flow Cytometry Instruments and Antibody Solutions.
  • Sharon Sanderson (Bio-Rad) – Simple, Robust, and Reliable: StarBright™ Dye Antibody Conjugation with TrailBlazer™ Kits.
14:45 – 15:00 | Coffee Break
15:00 – 15:45 | Keynote Speaker

Professor David Bending (University of Birmingham) – Revealing immune checkpoint function through application of fluorescent timer reporter proteins.

15:45 – 16:00 | Concluding Remarks & Prizes
16:00 | Reception, Facility Tour & Conference Close

Abstracts

Integrating Spectral Flow Cytometry and SCENITH to Characterise Age-Associated Metabolic Shifts in Immune Cell Subsets

 

Kristina Tomkova, Jonathan W. Lewis, Thomas A. Nicholson, Thomas A. Jackson, Helen M. McGettrick, Jon Hazeldine.

Department of Inflammation and Ageing, University of Birmingham, UK.


Altered cellular metabolism is a hallmark of ageing and is thought to contribute to immunosenescence and sarcopenia. However, age-associated metabolic shifts within specific immune and stromal cell subsets in the circulation and peripheral tissues remain poorly characterised. Improved high-resolution profiling of cellular metabolism may reveal novel targets to mitigate age-related cellular dysfunction. In this study, we aimed to validate a combined approach integrating spectral flow cytometry with Single-Cell Energetic Metabolism by Profiling Translation Inhibition (SCENITH) to enable detailed metabolic assessment at single-cell resolution.

We developed a novel 30-colour spectral flow cytometry panel capable of simultaneously identifying multiple T-cell, B-cell, NK-cell, monocyte, stromal, and endothelial cell subsets within a single sample of 300K peripheral blood mononuclear cells (PBMCs). SCENITH – a flow cytometry–based technique – quantifies the cellular metabolic activity by measuring puromycin incorporation into newly synthesised proteins following targeted metabolic inhibition. Using four inhibitors targeting distinct metabolic pathways, we assessed glucose dependence, mitochondrial dependence, glycolytic capacity, and fatty acid and amino acid oxidation capacity at the single-cell level.

Method optimisation demonstrated that anticoagulant used to collect blood samples has an effect on the cellular metabolism. Blood collected in EDTA tubes had better preserved cellular metabolic responsiveness compered to Lithium-heparin tubes, as evidenced by increased sensitivity to oligomycin and 2-deoxyglucose treatment. Both fresh and cryopreserved PBMCs responded appropriately to mitochondrial inhibition, while cryopreserved cells showed enhanced glycolytic reliance. As a proof-of-concept, PBMCs from aged (n=3) and young (n=3) volunteers were analysed using the combined platform. Distinct metabolic signatures were observed across immune cell subsets between age groups, reflected by differential dependencies on glucose, mitochondrial respiration, and oxidative pathways. Although limited by small sample size, these findings demonstrate the feasibility and translational potential of this integrated approach for high-resolution metabolic profiling in ageing research.

Using Spectral Flow Cytometry to Profile 𝛾𝛿 T-cells in Colorectal Cancer Tumours

 

Annabelle Bennett, Priyanka Chevour, Mohamed Hamed, Daniela Moreno Vicencio, Sascha Ott and Martin S. Davey.

Biomedical Science Directorate, Warwick Medical School, University of Warwick.

 

Colorectal cancer (CRC) is the second leading cause for cancer-associated mortality worldwide giving a vital urgency to find new immunotherapeutic targets. Unlike conventional ⍺β T-cells, γδ T-cells are a unique, unconventional lymphocyte subset that display both innate and adaptive characteristics. There are two major subsets of γδ T-cells; (1) innate-like V𝛿2+ γδ T-cells, primarily seen in blood, and (2) a population of tissue-associated V𝛿1+ γδ T-cells. Current understanding of γδ T-cells in CRC remains largely unknown, with both anti- and pro-tumour roles being uncovered. We hypothesise that clonally expanded tumour infiltrating γδ T-cells have distinct effector-like, tissue-resident and cytolytic phenotypes that may drive antigen-specific immune responses within the tumour microenvironment.

Methods

To investigate these phenotypes, we have developed a 38-colour spectral flow cytometry panel targeting both surface and intracellular proteins/peptides.  Using this panel, we analysed 18 matched blood, normal adjacent tissue (NAT) and tumour tissue samples from patients undergoing colorectal resection surgery.

Results

We find in blood that γδ T-cells, normally dominated by the V𝛿2+ T-cell subset, are often skewed towards CX3CR1+ CD45RAhi V𝛿1+ T-cells, consistent with a shift towards an effector-like phenotype. Within matched NAT and Tumour tissues, we predominantly find CD103+CD69+NKp46+ tissue-associated V𝛿1+ T-cells. Moreover, Vδ1+ T-cells in NAT had elevated CTLA-4 expression, and tumour infiltrating tissue-associated Vδ1+ T-cells had elevated PD-1 and CD11a expression.

Conclusions

Together, colorectal tissue-associated V𝛿1+ γδ T-cells readily infiltrate tumours and are phenotypically similar to NAT-associated V𝛿1+ γδ T-cells. However, tumour infiltrating V𝛿1+ γδ T-cells are altered in their immune checkpoint expression and adhesion molecules, that may lead to immune regulation by the tumour. Determining targets to reactivate anti-tumour tissue-associated γδ T-cells could provide potential new immunotherapeutic targets for colorectal cancer.

Methods to Reduce Variability in Flow Cytometry Cluster Analysis using Computationally Generated High-dimensional Fully-Synthetic data

 

Bradley Mason 1, Laura Justham 1, Liam Whitby 2 Alison Whitby 2, Stuart Scott 2, Samuel Nti 2, Jon Petzing 1

1 Wolfson School of Mechanical, Electrical & Manufacturing Engineering, Loughborough University, Loughborough, UK.

2 UK NEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK.

 

Modern flow cytometry (FC) is widely regarded as the de facto standard for high-throughput single-cell analysis in biological research, clinical and industrial settings. However, due to the intrinsic relative nature of empirical FC data, and the lack of definitive cell-by-cell cluster provenance associated with biological samples, users face significant challenges in validating the metrological precision and biological accuracy of FC data analysis. Effectuating challenges in the implementation of much needed quality assurance measures in FC analysis.

Our research involves the model-based generation of fully-controllable high-dimensional synthetic flow cytometry samples, which faithfully represent the characteristics of real-world data. All the while retaining the benefits of computational generation such as individual cell/event-level cluster lineage; contextual sample type/subtype adaptability and reproducible scalability of individual datasets.

In our work, we demonstrate that synthetic flow cytometry data can serve as both a verification tool to test and validate existing clustering methods, but also as a training and innovation tool to develop new approaches. For example, in manual clustering, quasi-identical samples quantify operator and software variability, providing absolute measures of gating uncertainty and bias across operators, training levels, laboratories and rare sample types. Benchmarking labelled synthetic data enables the evaluation of gating strategies or algorithmic clustering across differing sample subtypes. Furthermore, standards bodies, educators and developers can create synthetic ‘digital reference samples’ to support external quality assessment, refine standard operating procedures, and advance machine-learning applications.

In conclusion, labelled synthetic flow-cytometry datasets have a clear potential to improve diagnostic confidence in cytometry cluster analysis and tackle a critical challenge in regulatory-based quality assurance.

Illuminating T Cell Signalling: Optogenetics and FRET Sensors in Flow Cytometry

 

Emma Davey[1], Omer Dushek[2], John James[1]

[1] Warwick Medical School, University of Warwick.  [2] Sir William Dunn School of Pathology, University of Oxford.

 

Our immune system relies on T cells making appropriate and robust decisions to protect healthy cells whilst destroying pathogens or cancerous cells. To achieve this behaviour, extracellular cues from its receptors are converted into information through biochemical reactions within the cell that integrate to form a signalling network. Co-inhibitory receptors, such as Programmed Cell Death Protein 1 (PD-1), provide signals that suppress T cell activation and are of clinical interest as therapeutic targets for diseases such as cancer. Existing methods used to probe signalling networks lack the resolution needed to further the understanding of these complex systems, such as the decision-making processes used by T cells and the mechanism of action for co-inhibitory receptors.

We have therefore developed a toolkit of ratiometric fluorescent biosensors to probe the T cell signalling network of live cells using flow cytometry, capable of multiplexed measurements of multiple pathways simultaneously. By using these biosensors alongside novel optogenetic receptors, we can also precisely control T cell activation and co-inhibitory signals through illumination with blue light, whilst measuring clear signal outputs as well as achieving high temporal resolution.

This powerful, flow cytometry-based toolkit has enabled exploration of the dynamics of T cell activation signalling, as well as uncovering the differential impact of PD-1 on specific components of the signalling network. Future research will expand to study the impact of other co-inhibitory receptors, such as BTLA, TIGIT and LAG-3. We hope that creation of a detailed picture of T cell signalling dynamics through our novel methods will improve the understanding of these therapeutically important co-inhibitory receptors.

Flow Cytometric quantification of membrane polarisation in mycobacteria

 

Megan Atherton-Frisby, John Pearl.

Division of Microbiology and Infection, College of Life Sciences, University of Leicester.

 

Pulmonary infection by non-tuberculous mycobacteria (NTM) is an increasingly serious problem afflicting those over 55 years of age and those in the agricultural sector. Patients with pulmonary NTM infections suffer from antibiotic treatment failure rates approaching 50% within 5 years with many patients developing life-long chronic lung disease.

We hypothesise that clinical treatment failure is, in part, caused by the robust and flexible respiratory capacity of NTM. To test this hypothesis, we used the fast-growing Mycolicibacterium smegmatis as a model to investigate the bioenergetics of single bacilli using flow cytometry. Flow cytometry is an excellent analytic platform as it provides single-bacteria resolution of membrane polarisation.

We report the development and use of an assay using the fluorescent dye 3,3′-Diethyloxacarbocyanine Iodide (DiOC2(3)) as a differential reporter of bacterial respiratory capacity and overall health through the quantification of membrane polarisation, i.e., proton motive force. Validation of this assay included detection of bacterial-sized events by light scatter, fluorescent quantification of membrane polarisation in non-viable bacteria and modulation of membrane polarisation using specific respiratory inhibitors. Using this assay, we have identified the effects of different environmental growth conditions on membrane polarisation.

Based on these data, we conclude that DiOC2(3) provides the basis of a simple flow cytometric assay for mycobacterial membrane polarisation which allows for sensitive and specific quantification of bacterial bioenergetics.

Development of a Flow Cytometry Strategy for Phenotypic Characterisation of Human Placental Pericytes

 

Sofina Iqra, Jill R. Johnson.

School of Biosciences, Aston University.

 

Pericytes are perivascular stromal cells involved in vascular stability, tissue repair, and fibrotic remodelling. However, reliable phenotypic identification of human placental pericytes using flow cytometry remains technically challenging due to marker overlap with mesenchymal stromal cells (MSCs), culture-induced variability, and sensitivity to experimental handling. The project focuses on the development and optimisation of a multi-parameter flow cytometry workflow to enable consistent characterisation of primary human placental pericytes in vitro. Panel design incorporates canonical pericyte-associated markers, including PDGFRβ and CD146, alongside exclusion markers to minimise endothelial contamination. Emphasis is placed on antibody titration strategy, fluorophore selection, compensation planning, and implementation of fluorescence-minus-one (FMO) controls to improve signal resolution and reproducibility. Optimisation parameters under evaluation include dissociation method, cell density at harvest, viability dye selection and gating hierarchy to reduce background fluorescence and improve discrimination of low-expression markers. In parallel, protocols are being established to assess phenotypic stability during in vitro expansion and following induction of mesenchymal lineage differentiation. Reactive oxygen species (ROS) detection using CellROX-based assays is being incorporated to examine potential interactions between oxidative stress and pericyte phenotype. This methodological framework aims to generate a reproducible cytometric pipeline for stromal cell phenotyping and to support future investigations into pericyte plasticity and their contribution to fibrotic tissue remodelling.

Single cell cytokine analysis of blood T cells reveals increased CD8+ multifunctional type-2 cytokine responses during an eosinophilic exacerbation in COPD

 

Adam Wright1, Hnin Wint Wint Aung1, Rebecca Dale1, Abdullah Jamal1, Tracy Thornton2, Helen Evans2, Phoebe Ashley2, Sarah Edwards2, Hamish McAuley1,2, Omer Elneima1,2, David J Cousins1#, Neil Greening1,2#, Chris E Brightling1,2# (#co-last authors)

1Institute for Lung Health, NIHR Leicester BRC Respiratory & Infection Theme, School of Medical Sciences, Division of Respiratory Sciences, University of Leicester, Leicester, UK

2University Hospitals of Leicester NHS Trust, Leicester, UK.

 

COPD Exacerbations are life threatening events and a significant proportion of these are characterised as ‘type-2’, occurring in the context of elevated blood and/or sputum eosinophils.  The source of type-2 cytokines such as IL-4, 5 and 13, during this time, are poorly defined. We examined cytokine (IL-4, 5, 9, 13, 17, IFNg, GMCSF, TNF) production from CRTh2/CD294+ blood CD8+ and CD4+ Type-2 (defined as TC2 or TH2, respectively) T cells at the single cell level, during stable and exacerbation clinic visits. Blood eosinophils were greater than 0.3 (x109/L) and sputum eosinophils were > 3% of leukocytes during exacerbation.  Paired stable/exacerbation PBMCs (n=10) were stimulated with PMA/Ionomycin & Brefeldin A (5hrs). Intracellular cytokine staining was performed & analysed by cytometry.  Dimensionality reduction, clustering (X-shift) and cluster explorer were performed on a total of 114,000 events using FlowJo V10.10.  For each cluster, stable vs exacerbation comparisons were performed using a Wilcoxon signed rank test.

The total proportion of T2 cells were not different between stable and exacerbation visits. A total of 22 clusters were identified amongst T2 cells, spanning CD4+ (n=11), CD8+ (n=10) and CD4CD8 (n=1) subsets; all were present during stable and exacerbation visits.  Six TC2 clusters were all significantly increased at exacerbation compared to stable state whereas only one TH2 cluster was differential (decreased).  Cumulative analysis of all 6 TC2 clusters showed that they were significantly increased at exacerbation vs stable (14±11 vs 9±6%, respectively, p=0.014) visits.  Phenotypically, these comprised cells producing 2+ (TNF, GM-CSF), 3+ (TNF, IL-13 with GMCSF or IL-4), 4+ (TNF, IL-13, IL-4 with GMCSF or IL-5) or all 5 cytokines. Cytokine production from CD4+ subsets, including IL-5+, were not increased.  T2-derived IL-17, IFN-g and IL-9 were not detected.  These data suggest that TC2 rather than TH2 cell frequency may be important during eosinophilic exacerbations in COPD.

Optimising CAR T-Cell Therapy: Optogenetic Pulsatile Activation Drives Th9 Differentiation in CAR T Cells

 

Emma Jennings, Geroge Smith, Muna Fuyal, John James.

University of Warwick.

 

Background: Chimeric Antigen Receptor (CAR) T-cell therapy, involving the extraction of patient T-cells and arming them with receptors designed to target tumour specific antigens, has revolutionised the treatment of haematological malignancies in recent years. Despite the notable successes, CAR T-cell therapy only confers a durable response in 30-40 % of patients and exhibits a limited efficacy against solid tumours. Rapid exhaustion of CAR T-cells in response to persistent antigen stimulation is a known contributor to this limitation. Recently, T helper 9 (Th9) cells have been observed to have a more robust effectiveness against tumours, possessing an enhanced longevity.

Methods: Our work aims to explore the use of optically controllable pulsatile activation, thereby reducing the total CAR T-cell stimulation time, as a method of reducing cell exhaustion. Primary CD4+ T-cells are transduced with a photoactivatable anti-CD19 CAR construct. These OptoCAR T-cells are then co-cultured with CD19+ Raji B-cells under varying pulsatile sequences of light before flow cytometry was employed to explore their phenotype.

Results: Varied pulsatile signalling regimens led to altered expression of both co-inhibitory (e.g. PD-1) and co-stimulatory (e.g. ICOS) receptors on the surface of OptoCAR T-cells. We observed that pulsatile activation of OptoCAR T-cells was able to induce IL-9+ expression in the absence of TGF-β and IL-4 cytokine culture. Furthermore, a novel cytokine capture assay was developed and optimised to isolate live IL-9-secreting CAR+ T-cells for downstream functional assays and RNA sequencing.

Conclusion: Our data suggests that pulsatile activation warrants further investigation as a novel method for enhanced polarization of conventional CAR T-cells to a potentially more durable and effective therapeutic modality in the form of Th9 CAR T-cells.

Fibrosis-associated inflammatory mediators promote pericyte-to-myofibroblast transition

 

Jessica Ting, Kamila Janaszek, Somaia Ghanem, Thomas Foley, Jill R. Johnson.

School of Biosciences, Aston University.

 

Background: Pericytes are multifunctional progenitor cells associated with the microvasculature, and have been increasingly recognised as key contributors to tissue fibrosis through their ability to transform into myofibroblasts under inflammatory conditions. These changes to pericyte phenotype include increased cell motility in migration assays, acquisition of an elongated spindle shape, and elevated expression of the myofibroblast marker a-smooth muscle actin (a-SMA) and the cell migration marker N-cadherin. Furthermore, we have shown in recent studies that chronic inflammation increases pericyte responsiveness to the chemokine CXCL12 via increased cell surface expression of CXCR4. However, the inflammatory mediators driving the acquisition of myofibroblast features by pericytes are yet to be elucidated.

Methods: We assessed the impact of fibrosis-associated inflammatory mediators (CTGF, bFGF, TGF-β1, and IL-13; 10 ng/mL for 7 days) on pericyte-to-myofibroblast transition in vitro. Immunostaining was performed to evaluate the expression of myofibroblast markers (a-SMA) and changes in cell shape, scratch assays were performed to assess the rate of cell migration, and flow cytometry was performed to determine cell surface expression of CXCR4 and N-cadherin as indicators of increased cell motility.

Results: We observed clear induction of a myofibroblast phenotype in human pericytes with all tested mediators. TGF-β1 and IL-13 were the most potent inducers, demonstrated by increased α-SMA expression (p<0.01), acquisition of a spindle shape (p<0.001), and accelerated cell migration (p<0.001). Using flow cytometry, we also observed that the MFI of CXCR4 and N-cadherin increased with these treatments (p<0.001). Conversely, CTGF only partially induced a myofibroblast phenotype in pericytes, with increased a-SMA expression (p<0.05) and accelerated scratch closure (P<0.01), but no appreciable increase in CXCR4 or N-cadherin by flow cytometry. bFGF induced a spindle shape (p<0.01), but decreased CXCR4 and N-cadherin expression (p<0.001).

Conclusions: These results demonstrate that IL-13 and TGF-b1 are potent drivers of pericyte-to-mesenchymal transition and additionally confer enhanced responsiveness to the inflammatory chemokine CXCL12.

Posters

Molecular (Deep) UV-Excitable Antibody Conjugates with Tuneable Emission for Multicolour and Spectral Flow Cytometry

 

Sareena Sund, Sunil Claire, Michael Butlin, Parvez Iqbal, Jevgenijs Petrovs, Karolis Virzbickas, Jon A Preece.

ChromaTwist Ltd, Science Centre, University of Wolverhampton Science Park, Glaisher Drive, Wolverhampton, WV10 9RU, United Kingdom.

 

The chemical modularity of the ChromaTwist fluorescent dye platform has enabled the development of a portfolio of 70+ patented UV-excitable, molecular fluorophores emitting from blue through red, with potential extension into the near-infrared. These properties make them well suited for flow cytometry applications.

ChromaTwist dyes achieve long Stokes shift emissions without relying on tandem polymer dye architectures, thereby avoiding many of the associated manufacturing complexities and end-user limitations. The dye chemistry has been further developed to enable stable conjugation to antibodies, and the resulting conjugates have been validated in flow cytometry using both deep-UV (320 nm) and UV (355 nm) excitation on multicolour and spectral instruments.

Multicolour flow cytometry: The chemical tunability of ChromaTwist dyes allows fluorescent emission to be tailored to align with standard visible flow cytometry filters, with future extension into infrared channels. This enables the development of a portfolio of (deep) UV-excitable, molecular antibody conjugates suitable for multicolour panel design.

Spectral flow cytometry: The same tunability yields UV-excitable dyes with distinct spectral fingerprints under 320 nm and/or 355 nm excitation. This creates the opportunity for a large set of antibody conjugates excited by a single UV laser, expanding the multiplexing capacity of UV-based spectral flow cytometry.

We present data demonstrating the performance of ChromaTwist dye–antibody conjugates on multiple spectral platforms, including the SONY ID7000, Cytek Aurora and BD Biosciences S8, where distinct positively stained populations were obtained. Spectral similarity analyses indicate compatibility with existing commercial UV-excitable tandem polymer dyes, supporting the utility of ChromaTwist conjugates for inclusion in spectral flow cytometry panels.

ChromaTwist Dye Technology: A Modular, Scalable Platform for Bio-conjugatable (Deep) UV-Excitable Dyes Across the Visible Spectrum

 

Sunil Claire, Sareena Sund, Michael Butlin, Parvez Iqbal, Jevgenijs Petrovs, Karolis Virzbickas, Jon A. Preece.

ChromaTwist Ltd, Science Centre, University of Wolverhampton Science Park, Glaisher Drive, Wolverhampton, WV10 9RU, United Kingdom.

 

To date, ChromaTwist has synthesised 70+ UV-excitable fluorescent dyes via a modular and scalable chemical methodology, enabling diverse bioconjugation strategies for applications including flow cytometry.

This chemical versatility has enabled a detailed understanding of molecular structure–photophysics relationships, while simultaneously delivering a scalable dye technology suitable for cytometry and imaging workflows.

Thus, the ChromaTwist dyes are characterised by:

  • Tuneable and long Stokes shift fluorescent emissions: The ChromaTwist dye technology is based on a donor–acceptor system in which the acceptor group can be readily modified. Each chemical modification produces a shift in the emission spectrum, yielding a portfolio of 70+ dyes emitting from blue (395 nm) through to red (630 nm), with ongoing development towards near-IR emission. This tunability supports reduced spectral overlap and improved panel design.
  • High brightness: The ChromaTwist dyes exhibit high fluorescence quantum yields (30–70%), coupled with high molar absorptivities (>100,000 M⁻¹ cm⁻¹) at their absorption maxima, resulting in bright emission.
  • Aqueous buffer solubility: First-generation ChromaTwist dyes show good solubility in organic solvents and can be used in aqueous buffers via pre-dissolution in DMF/DMSO. Second-generation dyes incorporating anionic sulfonate groups exhibit significantly improved aqueous solubility, further broadening their bioconjugation potential.
  • A multitude of bioconjugation groups: ChromaTwist dyes can, in a modular and scalable fashion, incorporate reactive functional groups including –CO₂H, –N₃, –NH₂, active esters, –SH, alkenes and –Br. Active ester derivatives have enabled bioconjugation to CD4 and CD8 antibodies, with conjugates validated on both conventional and spectral flow cytometers using 355 nm excitation as well as deep 320 nm excitation — a largely under-explored region in commercial flow cytometry.

We will discuss the molecular design principles underpinning this versatile dye platform and its implications for next-generation flow cytometry reagents.

Functional Consequences of Cdc20 Cancer Variants: Disrupted MCC Interaction, Checkpoint Silencing, and Genomic Stability

 

Asma Omran and Andy Turnell.

University of Birmingham.

 

Cdc20 is a key co‑activator of the anaphase‑promoting complex/cyclosome (APC/C), essential for spindle assembly checkpoint (SAC) silencing and accurate mitotic progression. Germline Cdc20 variants have been identified in cancer and rare disease cohorts, yet their functional consequences remain unclear. Understanding how these variants influence checkpoint control and genomic stability is therefore essential.

To characterise the functional impact of cancer‑associated Cdc20 variants, we examined their effects on cell‑cycle dynamics and mitotic fidelity using flow cytometry. HeLa cell lines expressing wild‑type (WT) or variant Cdc20 were exposed to nocodazole to activate the SAC. After mitotic release, cells were ethanol‑fixed and stained with propidium iodide to quantify cell‑cycle stage and polyploid populations. In parallel, we performed immunoprecipitation (IP) pulldown assays to assess whether the variants altered binding to the mitotic checkpoint complex (MCC), a key regulator of APC/C inhibition and SAC maintenance.

Several Cdc20 variants showed increased polyploidy and elevated high‑ploidy DNA peaks compared with WT, consistent with impaired mitotic exit. IP/pulldown analyses revealed reduced interaction between select Cdc20 variants and MCC components, suggesting weakened checkpoint engagement and premature SAC silencing.

These data indicate that a subset of Cdc20 cancer variants disrupts MCC binding, deregulates SAC signalling, and compromises APC/C control. Together with the observed polyploidy, these findings support a model in which altered Cdc20 function contributes to mitotic defects and potential chromosomal instability.

Analysing immunometabolism using the SCENITH technique

 

Sepehr Qooja*1, Orla McGinty*1, Matthew Roberts1 Nicola Paine1, Nicolette Bishop1

1 National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.

 

Background: Single-cell energetic metabolism by profiling translation inhibition (SCENITH) is a novel flow cytometry-based method that allows investigation of the reliance of glycolysis or oxidative phosphorylation to cellular metabolism using metabolic pathway inhibitors. Puromycin is added as a surrogate marker of total adenosine triphosphate (ATP) production. This, minus the effect of adding the inhibitors, is used to estimate the reliance on each metabolic pathway for ATP production in different cell populations. This method has not been applied to an exercise setting before and may help identify novel mechanisms underlying the positive effects of regular physical activity on immune cell functions. Here we provide pilot data using this new technique to investigate changes in T cell metabolism after exercise.

Method:

Cells were incubated (40 min) with the inhibitors (100 mM 2-deoxy-glucose, 1 μM oligomycin or sequential combination of the drugs at these concentrations.  2 μg/mL Harrington reagent was used as control. Puromycin was added after 15 min of incubation. Cells were washed, lysed and dead cells excluded, before staining with cell surface antibodies. Cells were then fixed and permeabilised before intracellular staining for puromycin. The reliance on glycolytic and oxidative pathways, and capacity for glycolytic and oxidative metabolism when other the pathways are inhibited, were calculated from changes in the MFI of puromycin expression under the different conditions.

Based on the median fluorescence intensity of puromycin, the following equations could be used to determine OXPHOS and glycolysis dependencies of any population.

Result from CD4+ T-cells from a healthy participant:

100 * (247120-178405) / (247120-75039) = 35.93% Glucose dependence

100 * (247120-80402) / (247120-75039) = 96.88% Glucose dependence